162 related articles for article (PubMed ID: 31368817)
1. Luteolin exhibits anti-breast cancer property through up-regulating miR-203.
Gao G; Ge R; Li Y; Liu S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3265-3271. PubMed ID: 31368817
[TBL] [Abstract][Full Text] [Related]
2. Sinomenine restrains breast cancer cells proliferation, migration and invasion via modulation of miR-29/PDCD-4 axis.
Gao G; Liang X; Ma W
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3839-3846. PubMed ID: 31556312
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
4. Luteolin Induces Apoptosis by Up-regulating miR-34a in Human Gastric Cancer Cells.
Wu H; Huang M; Liu Y; Shu Y; Liu P
Technol Cancer Res Treat; 2015 Dec; 14(6):747-55. PubMed ID: 24988056
[TBL] [Abstract][Full Text] [Related]
5. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
6. Luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines.
Kim MJ; Woo JS; Kwon CH; Kim JH; Kim YK; Kim KH
Cell Biol Int; 2012 Apr; 36(4):339-44. PubMed ID: 22073986
[TBL] [Abstract][Full Text] [Related]
7. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
8. Antcin-A Modulates Epithelial-to-Mesenchymal Transition and Inhibits Migratory and Invasive Potentials of Human Breast Cancer Cells via p53-Mediated miR-200c Activation.
Kumar KJS; Vani MG; Hsieh HW; Lin CC; Wang SY
Planta Med; 2019 Jul; 85(9-10):755-765. PubMed ID: 31185503
[TBL] [Abstract][Full Text] [Related]
9. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
Fan X; Huang X; Li Z; Ma X
J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
[TBL] [Abstract][Full Text] [Related]
11. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
[TBL] [Abstract][Full Text] [Related]
13. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
14. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
15. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z
Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530
[TBL] [Abstract][Full Text] [Related]
16. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H
Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422
[TBL] [Abstract][Full Text] [Related]
17. Luteolin exerts pro-apoptotic effect and anti-migration effects on A549 lung adenocarcinoma cells through the activation of MEK/ERK signaling pathway.
Meng G; Chai K; Li X; Zhu Y; Huang W
Chem Biol Interact; 2016 Sep; 257():26-34. PubMed ID: 27474067
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.
Karimi Dermani F; Saidijam M; Amini R; Mahdavinezhad A; Heydari K; Najafi R
J Cell Biochem; 2017 Jun; 118(6):1547-1555. PubMed ID: 27918105
[TBL] [Abstract][Full Text] [Related]
19. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
20. Luteolin induces cell cycle arrest and apoptosis through extrinsic and intrinsic signaling pathways in MCF-7 breast cancer cells.
Park SH; Ham S; Kwon TH; Kim MS; Lee DH; Kang JW; Oh SR; Yoon DY
J Environ Pathol Toxicol Oncol; 2014; 33(3):219-31. PubMed ID: 25272060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
